ID: ALA2382118

Max Phase: Preclinical

Molecular Formula: C19H18FNO

Molecular Weight: 295.36

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(/C=C/c1ccc(N2CCCC2)cc1)c1ccc(F)cc1

Standard InChI:  InChI=1S/C19H18FNO/c20-17-8-6-16(7-9-17)19(22)12-5-15-3-10-18(11-4-15)21-13-1-2-14-21/h3-12H,1-2,13-14H2/b12-5+

Standard InChI Key:  SVNHQWWCFDSCRH-LFYBBSHMSA-N

Associated Targets(Human)

SNU-638 372 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

T47D 39041 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cathepsin L 3852 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cathepsin B 3822 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

DNA topoisomerase II alpha 6317 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

DNA topoisomerase I 7553 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 295.36Molecular Weight (Monoisotopic): 295.1372AlogP: 4.32#Rotatable Bonds: 4
Polar Surface Area: 20.31Molecular Species: NEUTRALHBA: 2HBD: 0
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 4.87CX LogP: 4.55CX LogD: 4.55
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.62Np Likeness Score: -1.00

References

1. Kim SH, Lee E, Baek KH, Kwon HB, Woo H, Lee ES, Kwon Y, Na Y..  (2013)  Chalcones, inhibitors for topoisomerase I and cathepsin B and L, as potential anti-cancer agents.,  23  (11): [PMID:23608763] [10.1016/j.bmcl.2013.03.106]

Source